♟️ Thursday 20 August 2026 Thu, 20 Aug 2026

57 Move Signals

Pacific Edge Advances with Draft Medicare Coverage for Cxbladder Tests Targeting $10.2 Billion Market

Pacific Edge’s draft Medicare Local Coverage Determination for its Cxbladder bladder cancer tests marks a pivotal step toward unlocking a $10.2 billion global market. Despite FY26 setbacks, the company is poised for growth with improved reimbursement prospects and strategic cost management.
20 Aug
Ada Torres
Ada Torres

Parkway Secures Key Approvals for QBMC, Pioneering CSG Brine Beneficial Use in Queensland

Parkway Corporate has cleared major regulatory hurdles for its Queensland Brine Management Complex, the first Australian facility authorised to convert coal seam gas waste brine into industrial chemicals, setting a new benchmark in sustainable waste management.
20 Aug
Maxwell Dee
Maxwell Dee

Connexion Mobility Grows Revenue 10 Percent, Expands with Hallam Road Acquisition

Connexion Mobility Ltd reported a 10% revenue increase to US$12.3 million for FY26, driven by its software platform expansion and the acquisition of Hallam Road Automotive. Profit after tax dipped slightly by 1%, while the company continued aggressive share buybacks to enhance shareholder value.
20 Aug
Sophie Babbage
Sophie Babbage

IDT Australia Narrows FY26 EBITDA Loss 85%, Eyes $50M Revenue by FY29 with $7.3M Capex

IDT Australia reports a sharp turnaround in FY26 with a 66% reduction in net loss and an 85% improvement in EBITDA, underpinned by a strategic reset and targeted investments in manufacturing capabilities.
20 Aug
Victor Sage
Victor Sage

Dart Mining Secures 865km2 Yamarna Gold Project and $2M Placement

Dart Mining (ASX:DTM) has agreed to acquire a large, underexplored gold and lithium project near the Gruyere mine in WA’s Yamarna district, backed by a $2 million capital raise to fund exploration and acquisition costs.
20 Aug
Maxwell Dee
Maxwell Dee

Viridis Secures $120M Equity as Colossus DFS Confirms Bankable Rare Earth Project

Viridis Mining and Minerals completes a Definitive Feasibility Study for its Colossus Rare Earth Project, confirming strong economics and project readiness, while securing $120 million in equity funding to advance into execution.
20 Aug
Maxwell Dee
Maxwell Dee

Perpetual Equity Reports 44% Profit Decline but Maintains 8.0 Cent Dividend

Perpetual Equity Investment Company (ASX: PIC) posted a 44.4% drop in net profit to $12.1 million for FY26, yet held its fully franked dividend steady at 8.0 cents per share and announced a shift to monthly dividend payments starting December 2026.
20 Aug
Claire Turing
Claire Turing

WCM Global Growth Lifts Dividend and Strengthens Capital Base with $84.8m Raise

WCM Global Growth reported a $66.7 million profit for FY2026, slightly down from last year, but boosted its final dividend and outlined a progressive dividend increase plan while completing a major $84.8 million capital raising.
20 Aug
Claire Turing
Claire Turing

Vicinity Centres Reports $1.39 Billion Profit as Premium Portfolio Advances

Vicinity Centres delivered a robust FY26 with a $1.39 billion statutory net profit, strategic acquisitions in key growth corridors, and a strengthened premium retail portfolio.
20 Aug
Eva Park
Eva Park

AnteoTech and Xerabrid Seal Deal to Advance Next-Gen Battery Separators

AnteoTech has formalised a strategic alliance with South Korea’s Xerabrid to co-develop and commercialise a breakthrough battery separator combining their proprietary technologies, targeting high-performance applications in eVTOL, EVs, and consumer electronics.
20 Aug
Victor Sage
Victor Sage

Zuleika Gold Urges Acceptance of CZR’s Scrip Takeover with Mineral Assets Valued at $6.1m

Zuleika Gold recommends shareholders accept CZR Resources’ off-market takeover offer, which values Zuleika’s mineral assets at a preferred $6.1 million. The independent expert deems the offer not fair but reasonable.
20 Aug
Maxwell Dee
Maxwell Dee

Dimerix Secures US$10 Million Upfront from Everest Medicines for DMX-200 in Asia

Dimerix has received a US$10 million upfront payment from Everest Medicines under a regional licensing deal for DMX-200 targeting FSGS in Greater China, South Korea and Southeast Asia. This deal marks Dimerix’s fifth commercial partnership for DMX-200, collectively worth up to A$1.9 billion in milestones and royalties.
20 Aug
Ada Torres
Ada Torres

Servcorp Posts Record FY26 Profit and Expands Global Footprint

Servcorp Limited delivered a record FY26 with a 24% rise in underlying NPBIT to $87 million, boosted dividends by 14%, and outlined a cautious yet optimistic FY27 growth strategy.
20 Aug
Victor Sage
Victor Sage

Eureka Group Holdings Delivers 29% EBITDA Growth Amid Portfolio Expansion and Strategic Acquisitions

Eureka Group Holdings (ASX: EGH) posted a 29% rise in underlying EBITDA for FY26, driven by rapid growth in its all-age rental segment and disciplined capital deployment, while statutory profit dipped due to one-off costs and tax adjustments.
20 Aug
Eva Park
Eva Park

Codan Delivers 30% Revenue Surge and 69% Profit Jump in FY26, Eyes 20% Growth

Codan Limited posted a robust FY26 with revenue up 30% to $875 million and net profit soaring 69% to $175 million, underpinned by strong demand in communications and metal detection segments. The company declared a fully franked final dividend of 29 cents, lifting the full-year payout by 70%.
20 Aug
Sophie Babbage
Sophie Babbage

Noumi Reports FY26 Revenue and EBITDA Growth Amid Convertible Notes Maturity Challenge

Noumi Limited lifted FY26 revenue by 8.8% and adjusted operating EBITDA by 7.6%, driven by Dairy & Nutritionals' strong earnings and strategic investments in Plant-based Milks. The company faces refinancing uncertainty with $610 million convertible notes maturing in May 2027, prompting a proposed acquisition by majority shareholder Arrovest.
20 Aug
Victor Sage
Victor Sage

Medical Developments International Posts 9% Revenue Growth and 566% Profit Surge on Penthrox Expansion

Medical Developments International (ASX:MVP) reported a 9% revenue increase to $42.6 million and a 566% jump in net profit to $0.6 million for FY26, driven by robust growth in its Pain Management segment and expanded paediatric approvals in Europe.
20 Aug
Ada Torres
Ada Torres

CZR Resources Launches $44.8 Million Takeover Bid for Zuleika Gold

CZR Resources Ltd (ASX:CZR) has launched an all-scrip off-market takeover bid for Zuleika Gold Limited (ASX:ZAG), offering 0.1742 CZR shares per Zuleika share, valuing Zuleika at approximately $44.8 million and representing a premium of over 40% to recent prices.
20 Aug
Maxwell Dee
Maxwell Dee

Universal Store Reports 13% Revenue Rise, Underlying EBIT Up 17%, CEO Transition Confirmed

Universal Store Holdings (ASX:UNI) posted a 12.9% revenue increase to $376.1 million in FY26, driven by strong like-for-like sales and store expansion. Underlying EBIT climbed 17.2% despite a $23.8 million impairment on CTC assets, while net profit after tax fell 21.6%. CEO Alice Barbery will retire in October, succeeded by George Do.
20 Aug
Logan Eniac
Logan Eniac

Zip Co Posts Record FY26 Profit as US Growth Accelerates and NZ Exit Announced

Zip Co Limited (ASX: ZIP) reported a 46% rise in net profit to $116.4 million for FY26, driven by strong US and ANZ market growth and record cash earnings of $268.9 million. The company also announced an orderly wind down of its New Zealand operations to focus on its core markets.
20 Aug
Claire Turing
Claire Turing

Dexus Delivers FY26 Guidance Amid APAC Litigation and Infrastructure Review

Dexus (ASX: DXS) reported steady FY26 results with AFFO of 45.0 cents per security and distributions of 37.0 cents, while initiating a strategic review of infrastructure funds following an adverse APAC court judgment.
20 Aug
Eva Park
Eva Park

Ridley’s FY26 Revenue Doubles on Fertilisers Deal but Profit Slumps Amid NovaqPro Impairment

Ridley Corporation’s FY26 results reveal a dramatic revenue surge fueled by its Incitec Pivot Fertilisers acquisition, alongside a significant profit drop due to a $31.8 million impairment on NovaqPro® and acquisition costs. The company declares a higher fully franked dividend, signaling confidence despite challenges.
20 Aug
Ada Torres
Ada Torres

Telix Pharmaceuticals Posts $38.3M Profit on 22% Revenue Surge, Boosts R&D and Partners with Regeneron

Telix Pharmaceuticals returned to profit in H1 2026, driven by strong U.S. sales of Illuccix and Gozellix, a $40 million upfront from Regeneron collaboration, and expanded R&D investment.
20 Aug
Ada Torres
Ada Torres

Cuscal Posts 49% Profit Surge with Indue and Paymark Acquisitions Fueling Growth

Cuscal Limited reported a 49% jump in statutory profit after tax to $42.7 million for FY26, driven by strategic acquisitions of Indue and Paymark that expanded its Australian and New Zealand footprint. The company declared a fully franked 7-cent final dividend and expects mid-twenties percentage growth in underlying profit and transaction volumes for FY27.
20 Aug
Claire Turing
Claire Turing